# An Open-Label Study of Serum Testosterone Levels in Non-dosed Females After Secondary Exposure to Testosterone Gel 1.62% Applied to the Upper Arms and Shoulders and Use of a T-shirt Barrier

> **NCT01130298** · PHASE1 · COMPLETED · sponsor: **AbbVie** · enrollment: 24 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Testosterone Gel 1.62%

## Key facts

- **NCT ID:** NCT01130298
- **Lead sponsor:** AbbVie
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-05
- **Primary completion:** 2010-05
- **Final completion:** 2010-05
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2017-12-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01130298

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01130298, "An Open-Label Study of Serum Testosterone Levels in Non-dosed Females After Secondary Exposure to Testosterone Gel 1.62% Applied to the Upper Arms and Shoulders and Use of a T-shirt Barrier". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01130298. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*